Provider QP7-23 MHCP Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Lunsumio™, Rebyota™, Sunlenca® Injection, and Vivimusta Read More
Provider QP8-23 Commercial Formulary Addition for Growth Hormone Therapeutic Class: Genotropin® (somatropin) Read More
Provider P77R1-22 Update: New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective January 30, 2023 Read More
Provider P6-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Sleep Management Clinical Guideline Updates Read More
Provider P7-23 Updated Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements Read More
Provider P8-23 Update: New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective April 3, 2023 Read More
Provider P9-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama Read More
